Tag: COVID-19
Improved formulations of nicotinamide riboside: A promising treatment for age-related disorders

Nicotinamide adenine dinucleotide (NAD+) is a co-enzyme involved in fundamental metabolic roles. Its levels decrease with aging, causing the development of age-related pathologies. NAD+ levels can be replenished by the intake of nicotinamide riboside (NR), a vitamin B3 analogue, which is naturally converted to NAD+. Regular use of NR supplementation is associated with improved outcomes in several cardiovascular, neurodegenerative, and […]
Maryland Stem Cell Research Fund: Cutting-edge regenerative medicine

The Maryland Stem Cell Research Fund (MCSRF) is devoted to developing and supporting innovative research into all aspects of stem-cell-based technologies. Through its diverse program structure, the MSCRF is intimately involved in every stage of the stem cell journey – from pre-clinical lab discovery to clinical patient trials. Importantly, it remains forward thinking, ensuring the next generation of researchers have […]
Read More… from Maryland Stem Cell Research Fund: Cutting-edge regenerative medicine
Aerosolised medicines may reduce the high risk of coronavirus infection

Rapid development of vaccines and other preventative measures has been vital in the response to the COVID-19 pandemic. Dr Michael Dubina, full member of the Russian Academy of Sciences, explores a novel method to reduce coronavirus infection risk. His pilot study explored the effects of an aerosolised combination medication in healthcare workers who had not previously been infected with the […]
Read More… from Aerosolised medicines may reduce the high risk of coronavirus infection
Integrating social media and CSR into strategic planning for a competitive advantage

The current theory for strategic planning involves assessing the business environment and identifying key assets within an organisation. Social media and corporate social responsibility (CSR) are currently considered unnecessary in strategy formulation. However, research conducted by Dr Gordon Bowen, associate lecturer at Northumbria University amongst other institutions, indicates that incorporating social media and CSR into an organisation’s strategy can allow […]
Read More… from Integrating social media and CSR into strategic planning for a competitive advantage
Lateral flow test detects SARS-CoV-2 neutralising antibodies

Novodiax Inc., under the guidance of Dr Jianfu Wang, has produced a novel lateral flow device called CoNAb. The device detects neutralising antibodies (NAbs) against SARS-CoV-2 (the virus responsible for COVID-19). Measuring NAbs is important to help us determine whether vaccination programmes are effective by measuring the level of immunity of vaccine recipients. They are also a vital tool for […]
Read More… from Lateral flow test detects SARS-CoV-2 neutralising antibodies
The Winton Centre: A vital time for nuanced risk communication

The Winton Centre for Risk and Evidence Communication, based at the University of Cambridge, UK, was established with a simple belief: that everyone deserves to hear accurate evidence concerning matters which are important to their lives. Never has this core tenet been so vital, or so widely scrutinised, as during the COVID-19 pandemic. We spoke with the Centre’s Executive Director, […]
Read More… from The Winton Centre: A vital time for nuanced risk communication
Scientific communication: Learning from the COVID-19 ‘Infodemic’

The COVID-19 pandemic has taken place in an age of rapid digital communication. Scientific voices can become lost in the noise. Worse, some were not accessible to the general public in the first place. On 7th December 2020, Project ECHO held a Global Series webinar: “COVID-19 global learning collaborative – science and the response to the COVID-19 ‘infodemic’”. The goal […]
Read More… from Scientific communication: Learning from the COVID-19 ‘Infodemic’
Statistics in the era of COVID-19: Measuring lockdowns with doubling time

The key to understanding SARS-CoV-2 (COVID-19) transmission is understanding the exponential growth of viral transmissions. The problem is that the concept of exponential growth is challenging for many to understand and interpret, including policymakers who need to make quick and informed decisions. Dr Biljana Stangeland, Executive Director/Chief Scientific Officer at Alv B, Norway, has been using doubling time – the […]
Read More… from Statistics in the era of COVID-19: Measuring lockdowns with doubling time
Encephalitis – when viral infections attack the brain

Professor Clayton Wiley from the University of Pittsburgh studies the emergence of new brain viral infections and their link to dementia. He examines encephalitis, an inflammation of the brain tissue that disrupts brain function and causes symptoms of variable severity, such as headache, fever, confusion, altered consciousness, loss of a sense, memory problems, trouble focusing or speaking, or even seizures. […]
Read More… from Encephalitis – when viral infections attack the brain
To Test, Or Not To Test – The COVID-19 Question

Dr Cristina Isabel Ibarra-Armenta is a lecturer at the Autonomous University of Sinaloa and UNICAF University. Dr Moisés Alejandro Alarcon-Osuna is a lecturer at the University of Guadalajara, and a member of the Mexican System of National Researchers from CONACYT (National Council for Science and Technology). Their research focuses on econometrics, regional analysis, and policy and technology change. In a […]
Read More… from To Test, Or Not To Test – The COVID-19 Question